Report cover image

Europe Graft-Versus-Host Disease (GVHD) Treatment Market

Publisher Data Bridge Market Research
Published Apr 01, 2025
Length 350 Pages
SKU # DAABD20406848

Description

Europe graft-versus-host disease (GVHD) treatment market is expected to reach USD 820 million by 2032, from USD 580 million in 2024 growing at the CAGR of 4.5% in the forecast period of 2025 to 2032.
Market Segmentation:
Europe Graft-Versus-Host Disease (GVHD) Treatment Market, By Treatment (Medication and Therapy), Type (Chronic GVHD, Acute GVHD, and Prophylactic), Gender (Female and Male), Age (Adults and Pediatric), Method of Administration (Oral, Intravenous, Topical, and Others), End User (Hospitals, Transplant Centers, Institutes, and Specialty Centers), Distribution Channel (Direct Tender, Retail Sales, and Others), By Country (Germany, France, Italy, U.K., Spain, Belgium, Russia, Switzerland, Denmark, and Rest of Europe) – Industry Trends and Forecast to 2032
Overview of Europe Graft-Versus-Host Disease (GVHD) Treatment Market Dynamics:

Driver
• Increasing Incidence of Hematopoietic Stem Cell Transplants (HSCT)

Restrain
• High Cost of Medications and Supportive Care

Opportunity
• Market Expansion through Strategic Initiatives and Partnership

Market Players

The key market players for Europe graft-versus-host disease (GVHD) treatment market are listed below:

• Bristol-Myers Squibb Company
• AbbVie Inc
• Novartis AG
• Janssen Global Services, LLC
• Mallinckrodt
• Incyte
• Sanofi
• Alkem Laboratories Ltd
• Astellas Pharma Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

350 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Europe Graft-versus-host Disease (Gvhd) Treatment Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market End User Coverage Grid
2.8 Dbmr Market Position Grid
2.9 Vendor Share Analysis
2.10 Secondary Sources
2.11 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestal Analysis
4.2 Porters Five Forces Analysis
5 Regulatory Framework
6 Market Overview
6.1 Drivers
6.1.1 Increasing Incidence Of Hematopoietic Stem Cell Transplants (Hsct)
6.1.2 Rising Awareness Campaigns And Patient Education
6.1.3 Advancements In Treatment Options For Graft-versus-host Disease (Gvhd)
6.2 Restraints
6.2.1 High Cost Of Medications And Supportive Care
6.2.2 Disease Heterogeneity In Graft-versus-host Disease (Gvhd) Implications For Treatment And Clinical Trials
6.3 Opportunities
6.3.1 Market Expansion Through Strategic Initiatives And Partnership
6.3.2 Growing Pipeline Of Innovative Drugs For Gvhd Treatment
6.3.3 Empowering Patient-centric Approach To Gvhd Treatment
6.4 Challenges
6.4.1 Stringent Regulations In Gvhd Therapies
6.4.2 Safety Concern And Complexities During Treatment
7 Europe Graft-versus-host-disease (Gvhd) Treatment Market, By Type
7.1 Overview
7.2 Chronic Gvhd
7.2.1 Corticosteroids
7.2.1.1 Prednisolone
7.2.1.2 Methylprednisolone
7.2.2 Immunosuppressive
7.2.2.1 Mycophenolate Mofetil (Mmf)
7.2.2.2 Methotrexate (Mtx)
7.2.2.3 Antithymocyte Globulin (Atg)
7.2.2.4 Others
7.2.3 Calcineurin Inhibitors
7.2.4 Others
7.2.5 Branded
7.2.5.1 Rezurock
7.2.5.2 Imbruvica
7.2.5.3 Jakafi
7.2.6 Generic
7.3 Acute Gvhd
7.3.1 Corticosteroids
7.3.1.1 Methylprednisolone
7.3.1.2 Prednisolone
7.3.2 Immunosuppressive
7.3.2.1 Mycophenolate Mofetil (Mmf)
7.3.2.2 Ruxolitinib
7.3.2.3 Others
7.3.3 Calcineurin Inhibitors
7.3.3.1 Tacrolimus (Tac)
7.3.3.2 Cyclosporin (Csa)
7.3.4 Others
7.4 Prophylactic
7.4.1 Cyclosporin (Csa)
7.4.2 Methotrexate (Mtx)
7.4.3 Tacrolimus (Tac)
7.4.4 Methylprednisolone
7.4.5 Others
7.4.6 Generic
7.4.7 Branded
8 Europe Graft-versus-host- Disease (Gvhd) Treatment Market, By Age
8.1 Overview
8.2 Adults
8.3 Pediatric
9 Europe Graft-versus-host- Disease (Gvhd) Treatment Market, By Gender
9.1 Overview
9.2 Female
9.3 Male
10 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Method Of Administration
10.1 Overview
10.2 Oral
10.3 Intravenous
10.4 Topical
10.5 Others
11 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Treatment
11.1 Overview
11.2 Medication
11.2.1 Corticosteroids
11.2.1.1 Methylprednisolone
11.2.1.2 Prednisolone
11.2.2 Immunosuppressive
11.2.2.1 Mycophenolate Mofetil (Mmf)
11.2.2.2 Methotrexate (Mtx)
11.2.2.3 Antithymocyte Globulin (Atg)
11.2.2.4 Others
11.2.3 Calcineurin Inhibitors
11.2.3.1 Tacrolimus (Tac)
11.2.3.2 Cyclosporin (Csa)
11.2.3.3 Others
11.2.4 Branded
11.2.4.1 Rezurock
11.2.4.2 Imbruvica
11.2.4.3 Jakafi
11.2.4.4 Orencia
11.2.4.5 Others
11.2.5 Generic
11.3 Therapy
12 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By End User
12.1 Overview
12.2 Hospitals
12.2.1 Public
12.2.2 Private
12.3 Transplant Centers
12.4 Institutes
12.5 Speciality Centers
13 Europe Graft-versus-host-disease (Gvhd) Treatment Market, By Distribution Channel
13.1 Overview
13.2 Direct Tender
13.3 Retail Sales
13.3.1 Hospital Pharmacy
13.3.2 Retail Pharmacy
13.3.3 Online Pharmacy
13.4 Others
14 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Region
14.1 Europe
14.1.1 Germany
14.1.2 France
14.1.3 Italy
14.1.4 U.K.
14.1.5 Spain
14.1.6 Belgium
14.1.7 Russia
14.1.8 Switzerland
14.1.9 Denmark
14.1.10 Rest Of Europe
15 Europe Graft Versus Host Disease (Gvhd) Treatment Market: Company Landscape
15.1 Company Share Analysis: Global
16 Swot Analysis
17 Company Profile
17.1 Bristol-myers Squibb Company
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Developments
17.2 Abbvie Inc.
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Company Share Analysis
17.2.4 Product Portfolio
17.2.5 Recent Developments
17.3 Janssen Europe Services, Llc
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Company Share Analysis
17.3.4 Product Portfolio
17.3.5 Recent Developments
17.4 Sanofi
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Developments/News
17.5 Incyte
17.5.1 Company Snapshot
17.5.2 Revenue Analysis
17.5.3 Company Share Analysis
17.5.4 Product Portfolio
17.5.5 Recent Developments
17.6 Alkem Laboratories Ltd.
17.6.1 Company Snapshot
17.6.2 Revenue Analysis
17.6.3 Product Portfolio
17.6.4 Recent Development
17.7 Astellas Pharma Inc.
17.7.1 Company Snapshot
17.7.2 Revenue Analysis
17.7.3 Product Portfolio
17.7.4 Recent Development
17.8 Mallinckrodt
17.8.1 Company Snapshot
17.8.2 Revenue Analysis
17.8.3 Product Portfolio
17.8.4 Recent Developments/News
17.9 Novartis Ag
17.9.1 Company Snapshot
17.9.2 Revenue Analysis
17.9.3 Product Portfolio
17.9.4 Recent Developments
18 Questionnaire
19 Related Reports
List Of Tables
Table 1 Europe Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 2 Europe Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 3 Europe Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 4 Europe Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 5 Europe Immunosuppressive In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 6 Europe Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 7 Europe Branded In Graft-versus-host Disease (Gvhd) Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 8 Europe Acute Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 9 Europe Acute Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 10 Europe Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 11 Europe Immunosuppressives In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 12 Europe Calcineurin Inhibitors In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 13 Europe Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 14 Europe Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 15 Europe Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 16 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Age, 2018-2032 (Usd Thousand)
Table 17 Europe Adults In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 18 Europe Pediatric In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 19 Europe Graft-versus-host- Disease (Gvhd) Treatment Market, By Gender, 2018-2032 (Usd Thousand)
Table 20 Europe Female In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 20218-2032 (Usd Thousand)
Table 21 Europe Male In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 22 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Method Of Administration, 2018-2032 (Usd Thousand)
Table 23 Europe Oral In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 24 Europe Intravenous In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 25 Europe Topical In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 26 Europe Others In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 27 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Treatment, 2018-2032 (Usd Thousand)
Table 28 Europe Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 29 Europe Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 30 Europe Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 31 Europe Immunosuppressive In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 32 Europe Calcineurin Inhibitors In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 33 Europe Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 34 Europe Branded In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 35 Europe Therapy In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 36 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By End User, 2018-2032 (Usd Thousand)
Table 37 Europe Hospitals In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 38 Europe Hospitals In Graft-versus-host Disease (Gvhd) Treatment Market, By End User, 2018-2032 (Usd Thousand)
Table 39 Europe Transplant Centers In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 40 Europe Institutes In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 41 Europe Specialty Centers In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 42 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand)
Table 43 Europe Direct Tender In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 44 Europe Retail Sales In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 45 Europe Retail Sales In Graft-versus-host Disease (Gvhd) Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand)
Table 46 Europe Others In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 47 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Country, 2018-2032 (Usd Thousand)
Table 48 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Treatment, 2018-2032 (Usd Thousand)
Table 49 Europe Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 50 Europe Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 51 Europe Immunosuppressive In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 52 Europe Calcineurin Inhibitors In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 53 Europe Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 54 Europe Branded In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 55 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 56 Europe Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 57 Methylprednisolone
Table 58 Europe Immunosuppressive In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 59 Europe Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 60 Europe Branded In Graft-versus-host Disease (Gvhd) Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 61 Europe Acute Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 62 Europe Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 63 Europe Immunosuppressives In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 64 Europe Calcineurin Inhibitors In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 65 Europe Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 66 Europe Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 67 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Gender, 2018-2032 (Usd Thousand)
Table 68 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Age, 2018-2032 (Usd Thousand)
Table 69 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Method Of Administration, 2018-2032 (Usd Thousand)
Table 70 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By End User, 2018-2032 (Usd Thousand)
Table 71 Europe Hospitals In Graft-versus-host Disease (Gvhd) Treatment Market, By End User, 2018-2032 (Usd Thousand)
Table 72 Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand)
Table 73 Europe Retail Sales In Graft-versus-host Disease (Gvhd) Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand)
Table 74 Germany Graft-versus-host Disease (Gvhd) Treatment Market, By Treatment, 2018-2032 (Usd Thousand)
Table 75 Germany Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 76 Germany Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 77 Germany Immunosuppressive In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 78 Germany Calcineurin Inhibitors In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 79 Germany Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 80 Germany Branded In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 81 Germany Graft-versus-host Disease (Gvhd) Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 82 Germany Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 83 Germany Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 84 Germany Immunosuppressive In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 85 Germany Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 86 Germany Branded In Graft-versus-host Disease (Gvhd) Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 87 Germany Acute Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 88 Germany Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 89 Germany Immunosuppressives In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 90 Germany Calcineurin Inhibitors In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 91 Germany Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 92 Germany Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 93 Germany Graft-versus-host Disease (Gvhd) Treatment Market, By Gender, 2018-2032 (Usd Thousand)
Table 94 Germany Graft-versus-host Disease (Gvhd) Treatment Market, By Age, 2018-2032 (Usd Thousand)
Table 95 Germany Graft-versus-host Disease (Gvhd) Treatment Market, By Method Of Administration, 2018-2032 (Usd Thousand)
Table 96 Germany Graft-versus-host Disease (Gvhd) Treatment Market, By End User, 2018-2032 (Usd Thousand)
Table 97 Germany Hospitals In Graft-versus-host Disease (Gvhd) Treatment Market, By End User, 2018-2032 (Usd Thousand)
Table 98 Germany Graft-versus-host Disease (Gvhd) Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand)
Table 99 Germany Retail Sales In Graft-versus-host Disease (Gvhd) Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand)
Table 100 France Graft-versus-host Disease (Gvhd) Treatment Market, By Treatment, 2018-2032 (Usd Thousand)
Table 101 France Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 102 France Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 103 France Immunosuppressive In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 104 France Calcineurin Inhibitors In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 105 France Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 106 France Branded In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 107 France Graft-versus-host Disease (Gvhd) Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 108 France Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 109 France Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 110 France Immunosuppressive In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 111 France Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 112 France Branded In Graft-versus-host Disease (Gvhd) Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 113 France Acute Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 114 France Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 115 France Immunosuppressives In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 116 France Calcineurin Inhibitors In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 117 France Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 118 France Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 119 France Graft-versus-host Disease (Gvhd) Treatment Market, By Gender, 2018-2032 (Usd Thousand)
Table 120 France Graft-versus-host Disease (Gvhd) Treatment Market, By Age, 2018-2032 (Usd Thousand)
Table 121 France Graft-versus-host Disease (Gvhd) Treatment Market, By Method Of Administration, 2018-2032 (Usd Thousand)
Table 122 France Graft-versus-host Disease (Gvhd) Treatment Market, By End User, 2018-2032 (Usd Thousand)
Table 123 France Hospitals In Graft-versus-host Disease (Gvhd) Treatment Market, By End User, 2018-2032 (Usd Thousand)
Table 124 France Graft-versus-host Disease (Gvhd) Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand)
Table 125 France Retail Sales In Graft-versus-host Disease (Gvhd) Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand)
Table 126 Italy Graft-versus-host Disease (Gvhd) Treatment Market, By Treatment, 2018-2032 (Usd Thousand)
Table 127 Italy Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 128 Italy Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 129 Italy Immunosuppressive In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 130 Italy Calcineurin Inhibitors In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 131 Italy Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 132 Italy Branded In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 133 Italy Graft-versus-host Disease (Gvhd) Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 134 Italy Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 135 Italy Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 136 Italy Immunosuppressive In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 137 Italy Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 138 Italy Branded In Graft-versus-host Disease (Gvhd) Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 139 Italy Acute Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 140 Italy Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 141 Italy Immunosuppressives In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 142 Italy Calcineurin Inhibitors In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 143 Italy Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2018-2032 (Usd Thousand)
Table 144 Italy Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 145 Italy Graft-versus-host Disease (Gvhd) Treatment Market, By Gender, 2018-2032 (Usd Thousand)
Table 146 Italy Graft-versus-host Disease (Gvhd) Treatment Market, By Age, 2018-2032 (Usd Thousand)
Table 147 Italy Graft-versus-host Disease (Gvhd) Treatment Market, By Method Of Administration, 2018-2032 (Usd Thousand)
Table 148 Italy Graft-versus-host Disease (Gvhd) Treatment Market, By End User, 2018-2032 (Usd Thousand)
Table 149 Italy Hospitals In Graft-versus-host Disease (Gvhd) Treatment Market, By End User, 2018-2032 (Usd Thousand)
List Of Figures
Figure 1 Europe Graft-versus-host Disease (Gvhd) Treatment Market: Segmentation
Figure 2 Europe Graft-versus-host Disease (Gvhd) Treatment Market: Data Triangulation
Figure 3 Europe Graft-versus-host Disease (Gvhd) Treatment Market: Droc Analysis
Figure 4 Europe Graft-versus-host Disease (Gvhd) Treatment Market: Europe Vs Regional Market Analysis
Figure 5 Europe Graft-versus-host Disease (Gvhd) Treatment Market: Company Research Analysis
Figure 6 Europe Graft-versus-host Disease (Gvhd) Treatment Market: Interview Demographics
Figure 7 Europe Graft-versus-host Disease (Gvhd) Treatment Market: Market End User Coverage Grid
Figure 8 Europe Graft-versus-host Disease (Gvhd) Treatment Market: Dbmr Market Position Grid
Figure 9 Europe Graft-versus-host Disease (Gvhd) Treatment Market: Vendor Share Analysis
Figure 10 Europe Graft-versus-host Disease (Gvhd) Treatment Market: Segmentation
Figure 11 The Growing Number Of Stem Cell Transplantations Is Driving The Growth Of The Europe Graft-versus-host Disease (Gvhd) Treatment Market From 2025 To 2032
Figure 12 The Treatment Segment Is Expected To Account For The Largest Share Of The Europe Graft-versus-host Disease (Gvhd) Treatment Market In 2025 And 2032
Figure 13 Europe Graft-versus-host Disease (Gvhd) Treatment Market: Executive Summary
Figure 14 Strategic Decisions
Figure 15 Two Segments Comprise The Europe Graft-versus-host Disease (Gvhd) Treatment Market, By Treatment
Figure 16 Drivers, Restraints, Opportunities, And Challenges Of The Europe Graft-versus-host Disease (Gvhd) Treatment Market
Figure 17 Europe Graft-versus-host-disease (Gvhd) Treatment Market: By Type, 2024
Figure 18 Europe Graft-versus-host-disease (Gvhd) Treatment Market: By Type, 2025-2032 (Usd Thousand)
Figure 19 Europe Graft-versus-host-disease (Gvhd) Treatment Market: By Type, Cagr (2025-2032)
Figure 20 Europe Graft-versus-host-disease (Gvhd) Treatment Market: By Type, Lifeline Curve
Figure 21 Europe Graft-versus-host- Disease (Gvhd) Treatment Market: By Age, 2024..
Figure 22 Europe Graft-versus-host- Disease (Gvhd) Treatment Market: By Age, 2025-2032 (Usd Thousand)
Figure 23 Europe Graft-versus-host- Disease (Gvhd) Treatment Market: By Age, Cagr (2025-2032)
Figure 24 Europe Graft-versus-host- Disease (Gvhd) Treatment Market: By Age, Lifeline Curve
Figure 25 Europe Graft-versus-host- Disease (Gvhd) Treatment Market: By Gender, 2024
Figure 26 Europe Graft-versus-host- Disease (Gvhd) Treatment Market: By Gender, 2025-2032 (Usd Thousand)
Figure 27 Europe Graft-versus-host- Disease (Gvhd) Treatment Market: By Gender, Cagr (2025-2032)
Figure 28 Europe Graft-versus-host- Disease (Gvhd) Treatment Market: By Gender, Lifeline Curve
Figure 29 Europe Graft-versus-host Disease (Gvhd) Treatment Market: By Method Of Administration, 2024
Figure 30 Europe Graft-versus-host Disease (Gvhd) Treatment Market: By Method Of Administration, 2025-2032 (Usd Thousand)
Figure 31 Europe Graft-versus-host Disease (Gvhd) Treatment Market: By Method Of Administration, Cagr (2025-2032)
Figure 32 Europe Graft-versus-host Disease (Gvhd) Treatment Market: By Method Of Administration, Lifeline Curve
Figure 33 Europe Graft-versus-host Disease (Gvhd) Treatment Market: By Treatment, 2024
Figure 34 Europe Graft-versus-host Disease (Gvhd) Treatment Market: By Treatment, 2025-2032 (Usd Thousand)
Figure 35 Europe Graft-versus-host Disease (Gvhd) Treatment Market: By Treatment, Cagr (2025-2032)
Figure 36 Europe Graft-versus-host Disease (Gvhd) Treatment Market: By Treatment, Lifeline Curve
Figure 37 Europe Graft-versus-host-disease (Gvhd) Treatment Market: By End User 2024
Figure 38 Europe Graft-versus-host-disease (Gvhd) Treatment Market: By End User, 2025-2032 (Usd Thousand)
Figure 39 Europe Graft-versus-host-disease (Gvhd) Treatment Market: End User, Cagr (2025-2032)
Figure 40 Europe Graft-versus-host-disease (Gvhd) Treatment Market: End User, Lifeline Curve
Figure 41 Europe Graft-versus-host-disease (Gvhd) Treatment Market: By Distribution Channel, 2024
Figure 42 Europe Graft-versus-host-disease (Gvhd) Treatment Market: By Distribution Channel, 2025-2032 (Usd Thousand)
Figure 43 Europe Graft-versus-host-disease (Gvhd) Treatment Market: Distribution Channel, Cagr (2025-2032)
Figure 44 Europe Graft-versus-host-disease (Gvhd) Treatment Market: Distribution Channel, Lifeline Curve
Figure 45 Europe Graft-versus-host Disease (Gvhd) Treatment Market: Snapshot (2024)
Figure 46 Europe Graft Versus Host Disease (Gvhd) Treatment Market: Company Share 2024 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us